A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NCT07321106 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cartography Biosciences